HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Setsuya Aiba Selected Research
Setsuya Aiba Research Topics
Disease
49
Neoplasms (Cancer)
01/2021 - 03/2004
43
Melanoma (Melanoma, Malignant)
09/2021 - 07/2004
16
Inflammation (Inflammations)
10/2022 - 10/2002
14
Psoriasis (Pustulosis Palmaris et Plantaris)
11/2021 - 08/2002
11
Mycosis Fungoides
11/2020 - 01/2006
8
Atopic Dermatitis (Atopic Eczema)
01/2022 - 02/2003
8
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
02/2021 - 09/2016
8
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 09/2014
6
Skin Diseases (Skin Disease)
10/2020 - 10/2002
5
Autoimmune Diseases (Autoimmune Disease)
10/2022 - 09/2012
5
Vitiligo
07/2021 - 10/2013
5
Pemphigus (Pemphigus Vulgaris)
03/2021 - 04/2009
5
Lymphoma (Lymphomas)
11/2020 - 01/2004
5
Extramammary Paget Disease (Paget Disease, Extramammary)
01/2019 - 11/2012
4
Bullous Pemphigoid (Pemphigoid)
11/2018 - 01/2014
4
Infections
01/2018 - 08/2002
4
Carcinoma (Carcinomatosis)
01/2017 - 09/2012
3
Hypersensitivity (Allergy)
12/2022 - 12/2005
3
Rosacea (Acne Rosacea)
05/2022 - 11/2014
3
Pruritus (Itching)
09/2021 - 01/2017
3
Lichen Planus (Lichen Ruber Planus)
01/2021 - 10/2002
3
Eczema
01/2020 - 10/2002
3
Carcinogenesis
01/2020 - 09/2018
3
Acne Vulgaris
03/2019 - 09/2014
3
Dermatitis
01/2019 - 10/2002
3
Erythema
02/2018 - 09/2012
3
Drug Eruptions (Drug Eruption)
05/2015 - 10/2003
3
Contact Dermatitis (Eczema, Contact)
07/2014 - 09/2009
3
Hypohidrosis
11/2013 - 01/2002
3
Alopecia Areata
01/2013 - 03/2003
3
Hemangiosarcoma (Angiosarcoma)
01/2013 - 01/2012
3
Wounds and Injuries (Trauma)
04/2007 - 05/2005
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2022 - 05/2012
2
Lymphomatoid Papulosis
01/2022 - 02/2018
2
Localized Scleroderma (Morphea)
06/2021 - 01/2015
2
Fever (Fevers)
01/2021 - 06/2020
2
Necrosis
12/2020 - 04/2009
2
Sarcoma (Soft Tissue Sarcoma)
09/2020 - 05/2013
Drug/Important Bio-Agent (IBA)
26
Nivolumab
IBA
09/2021 - 06/2016
14
Chemokines
IBA
03/2021 - 11/2015
13
Ipilimumab
IBA
09/2021 - 09/2016
11
Biomarkers (Surrogate Marker)
IBA
01/2021 - 02/2010
10
Antibodies
IBA
10/2022 - 09/2017
8
Interleukin-17 (Interleukin 17)
IBA
11/2021 - 09/2012
8
trametinib
IBA
03/2021 - 02/2018
8
dabrafenib
IBA
03/2021 - 02/2018
7
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
09/2021 - 09/2017
7
pembrolizumab
IBA
01/2021 - 01/2018
7
Cytokines
IBA
01/2020 - 11/2003
6
Immunoglobulin E (IgE)
IBA
11/2021 - 11/2005
6
Therapeutic Uses
IBA
01/2020 - 11/2005
6
Immune Checkpoint Inhibitors
IBA
01/2020 - 05/2017
6
Periostin
IBA
12/2017 - 01/2015
5
mogamulizumab
IBA
11/2020 - 01/2018
5
Steroids
IBA
10/2020 - 01/2006
5
Antigens
IBA
09/2020 - 08/2002
5
Bexarotene (LGD1069)
FDA Link
06/2020 - 01/2017
5
Proteins (Proteins, Gene)
FDA Link
01/2019 - 11/2005
5
Adenosine Triphosphate (ATP)
IBA
06/2017 - 04/2009
5
Haptens
IBA
06/2016 - 10/2007
4
Immunoglobulin G (IgG)
IBA
10/2022 - 09/2003
4
Infliximab (Remicade)
FDA Link
11/2021 - 07/2015
4
Interleukin-23 (Interleukin 23)
IBA
11/2021 - 05/2018
4
Proto-Oncogene Proteins B-raf
IBA
09/2021 - 01/2019
4
Adrenal Cortex Hormones (Corticosteroids)
IBA
07/2021 - 01/2006
4
Interferons
IBA
01/2021 - 01/2006
4
Ligands
IBA
11/2020 - 01/2019
4
Enzymes
IBA
10/2020 - 04/2009
4
Denosumab
FDA Link
01/2020 - 01/2017
4
Messenger RNA (mRNA)
IBA
01/2020 - 11/2003
4
Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
IBA
01/2020 - 01/2017
4
Retinoids
IBA
01/2019 - 01/2004
4
Interleukin-12 (IL 12)
IBA
05/2018 - 02/2003
4
Interferon-gamma (Interferon, gamma)
IBA
09/2016 - 02/2003
3
Anti-Bacterial Agents (Antibiotics)
IBA
08/2023 - 01/2018
3
Autoantibodies
IBA
10/2022 - 04/2009
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2021 - 04/2009
3
Interleukins
IBA
11/2021 - 04/2009
3
binimetinib
IBA
03/2021 - 06/2020
3
encorafenib
IBA
03/2021 - 06/2020
3
Etoposide (VP 16)
FDA Link
Generic
01/2020 - 01/2016
3
Programmed Cell Death 1 Receptor
IBA
01/2019 - 01/2018
3
Prednisolone (Predate)
FDA Link
Generic
11/2018 - 04/2009
3
Ointments (Pastes)
IBA
05/2018 - 01/2005
3
RANK Ligand
IBA
01/2018 - 01/2016
3
Matrix Metalloproteinases (MMPs)
IBA
01/2018 - 11/2012
3
Peplomycin
IBA
01/2017 - 09/2014
2
Cetuximab (Erbitux)
FDA Link
12/2022 - 07/2021
2
Histamine Antagonists (Antihistamines)
IBA
09/2021 - 08/2003
2
MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)
IBA
09/2021 - 09/2019
2
Methylprednisolone
FDA Link
Generic
07/2021 - 01/2020
2
Immunoglobulins (Immunoglobulin)
IBA
06/2021 - 05/2018
2
Hydrocortisone (Cortisol)
FDA Link
Generic
10/2020 - 05/2011
2
Glucocorticoids
IBA
10/2020 - 05/2011
2
Dacarbazine (DIC)
FDA Link
Generic
09/2020 - 01/2018
Therapy/Procedure
50
Therapeutics
01/2023 - 01/2006
10
Immunotherapy
12/2020 - 11/2005
6
Drug Therapy (Chemotherapy)
02/2021 - 09/2014
5
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
09/2021 - 05/2017
4
Radiotherapy
05/2019 - 01/2012